J Vollmer-Haase, P Young, E B Ringelstein. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultCamptothecin/therapeutic useCyclophosphamide/adverse effectsFemaleHumansImmunosuppressive Agents/adverse effectsLeukoencephalopathy, Progressive Multifocal/chemically inducedLeukoencephalopathy, Progressive Multifocal/drug therapyLupus Erythematosus, Systemic/drug therapyTopoisomerase I Inhibitors
Substances: See more » Immunosuppressive AgentsTopoisomerase I InhibitorsCyclophosphamideCamptothecin
Year: 1997 PMID: 9149702 DOI: 10.1016/S0140-6736(05)63201-1
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321